Replay LSI2021 Emerging Medtech Summit

Play Now
innovation hub

ThermopeutiX is Profiled in this Database

Updated At 03 Mar, 2020

Start Free 7 Day Trial Now
Partial description of this company

The TwinFlo™ Catheter is designed to treat and protect the ischemic brain by providing rapid and selective cerebral hypothermia. It will offer a major advancement to the technology and treatment paradigms available to patients facing serious neurological damage and death. The unique design of TwinFlo™ results in more rapid and deeper localized cooling of the brain, while maintaining the remainder of the body at normal temperature (selective hypothermia). This differs from other hypothermia treatments that are unable to bring the brain to a sufficiently low temperature without significant total-body cooling and detrimental systemic effects. The design also permits selective drug and/or device delivery concurrent with the hypothermia treatment.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of ThermopeutiX plus 4970 other startups.

Start Free 7 Day Trial Now

Learn More About ThermopeutiX

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

CEO presentation


Our Clients